N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine

C34H33BN4O2 — CID 144830896

IUPACN,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine
SMILESCC1(C)OB(C2=Cc3c(c4ccccc4n3-c3ncc(N(c4ccccc4)c4ccccc4)cn3)CC2)OC1(C)C
InChIInChI=1S/C34H33BN4O2/c1-33(2)34(3,4)41-35(40-33)24-19-20-29-28-17-11-12-18-30(28)39(31(29)21-24)32-36-22-27(23-37-32)38(25-13-7-5-8-14-25)26-15-9-6-10-16-26/h5-18,21-23H,19-20H2,1-4H3
InChIKeyVEQNAGCJNVRMNC-UHFFFAOYSA-N
MW540.48 g/mol
LogP7.85
Rot. Bonds5

About N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine

N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine (PubChem CID 144830896) has the molecular formula C34H33BN4O2 and a molecular weight of 540.48 g/mol. Its IUPAC name is N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine.

Molecular Properties

Compound NameN,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine
PubChem CID144830896
Molecular FormulaC34H33BN4O2
Molecular Weight540.48 g/mol
Exact Mass540.27
IUPAC NameN,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine
SMILESCC1(C)OB(C2=Cc3c(c4ccccc4n3-c3ncc(N(c4ccccc4)c4ccccc4)cn3)CC2)OC1(C)C
InChIInChI=1S/C34H33BN4O2/c1-33(2)34(3,4)41-35(40-33)24-19-20-29-28-17-11-12-18-30(28)39(31(29)21-24)32-36-22-27(23-37-32)38(25-13-7-5-8-14-25)26-15-9-6-10-16-26/h5-18,21-23H,19-20H2,1-4H3
InChIKeyVEQNAGCJNVRMNC-UHFFFAOYSA-N
XLogP7.85
TPSA52.41 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500540.48
LogP ≤ 57.85
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine?
The IUPAC name of N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine (CID 144830896) is N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine.
What is the SMILES notation for N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine?
The canonical SMILES for N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine is CC1(C)OB(C2=Cc3c(c4ccccc4n3-c3ncc(N(c4ccccc4)c4ccccc4)cn3)CC2)OC1(C)C.
What is the InChIKey of N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine?
The InChIKey is VEQNAGCJNVRMNC-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H33BN4O2/c1-33(2)34(3,4)41-35(40-33)24-19-20-29-28-17-11-12-18-30(28)39(31(29)21-24)32-36-22-27(23-37-32)38(25-13-7-5-8-14-25)26-15-9-6-10-16-26/h5-18,21-23H,19-20H2,1-4H3.
What are the key properties of N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine?
N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine has a molecular weight of 540.48 g/mol, XLogP of 7.85, 5 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-diphenyl-2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydrocarbazol-9-yl]pyrimidin-5-amine is sourced from PubChem (CID 144830896), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).